IL31 and systemic sclerosis: In addition, IL-31 also plays a role in TH2-driven and autoimmune diseases such as contact dermatitis, urticaria, mastocytosis, allergic rhinitis; but also systemic sclerosis, dermatomyositis, and lupus erythematosus (4–12).